Cidara Therapeutics Inc.

CDTX | NASDAQ

Price Alert Chart Builder DCF Calculator

$221.38

$0 (0.00%)

At close: Jan 8, 2026, 9:30 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.00%

(1D)

Key Statistics

Market Data

Market Cap $5.61B

1D Range

221.38 221.38

52W Range

15.22 221.42

Valuation (TTM)

PE -18.79

PB 13.29

EV/EBITDA -28.03

Valuation (NTM)

Forward PE N/A

Forward PEG -24.33

Price Target $177.88

Cash Flow

FCF Yield -2.4%

SBC Adj. FCF Yield -2.5%

SBC Impact -7.2%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y -109.3% | -38.0%

Dil EPS 3Y | 5Y -13.7% | 2.9%

FCF 3Y | 5Y -47.1% | -49.0%

Returns

ROA -25.5%

ROE -37.3%

ROIC -33.3%

Financial Health

Net Cash

$291.67M

Current Ratio 4.62

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases ...

Sector Healthcare

Industry Biotechnology

Employees 38

IPO Date Apr 14, 2015

Website www.cidara.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Hold

Price Target

$170

Downside

-23.21%

Buy (3)

Hold (3)

Sell (0)

Analyst Details ➞